Location History:
- Cheshire, GB (2007)
- Macclesfield, GB (2008)
Company Filing History:
Years Active: 2007-2008
Title: Barry Raymond Hayter: Innovator in Medicinal Chemistry
Introduction
Barry Raymond Hayter is a distinguished inventor based in Cheshire, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target critical biological pathways.
Latest Patents
Hayter holds 2 patents, with his latest innovations focusing on novel compounds. One of his patents involves "Condensed pyridines and pyrimidines with tie2 (TEK) activity," which describes a compound designed to produce an anti-angiogenic effect in warm-blooded animals, including humans. Another notable patent is for "Vinyl phenyl derivatives as GLK activators," which relates to compounds useful in treating diseases mediated through glucokinase, such as type 2 diabetes.
Career Highlights
Barry Hayter is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work has been instrumental in advancing therapeutic options for various medical conditions.
Collaborations
Throughout his career, Hayter has collaborated with notable colleagues, including Gordon Stuart Currie and Rodney Brian Hargreaves. These partnerships have contributed to the successful development of innovative medicinal compounds.
Conclusion
Barry Raymond Hayter's contributions to medicinal chemistry and his innovative patents underscore his role as a key figure in the field. His work continues to impact the development of new treatments for critical health issues.